Red Light Closes Acquisition of Mera Life Sciences and Files Quarterly Financial Statements
Retrieved on:
Tuesday, August 31, 2021
Psilocybin, CSE, Labour, Research, Drug discovery, Lysergic acid, Smart, Achievement, Partnership, Fishery, Plant, 5-Methoxy-N,N-diisopropyltryptamine, Ayahuasca, License, Ginger, SEDAR, CEO, Sale, Sassafras, Industry, FSE, Methylenedioxy, SVG, Government, Canadian Securities Exchange, DMT, Lysergic acid diethylamide, Red light, LSD, Mission statement, Company, Mescaline, Growth, Acquisition, Science, Moringa, EVP, THC, OTC Markets Group, Forestry, Patient, MDMA, Pharmaceutical industry, Online shopping
Separately, the Company has closed its previously announced acquisition of Mera Life Sciences ("Mera").
Key Points:
- Separately, the Company has closed its previously announced acquisition of Mera Life Sciences ("Mera").
- Shapiro added: "Separately, we have also completed the acquisition of Mera and its coveted psychedelic licenses in St. Vincent and the Grenadines.
- "Working through the Mera acquisition with the various stakeholders involved has been a really fantastic experience," said William Lay, EVP and Chief Strategy Officer of Red Light Holland.
- Upon closing of the transaction, the Company issued 700,000 Red Light Shares to the vendor of Mera.